We serve Chemical Name:3-Amino-5-ethoxyisoxazole CAS:32326-26-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-Amino-5-ethoxyisoxazole
CAS.NO:32326-26-4
Synonyms:3-Amino-5-ethoxyisoxazole;5-ethoxyisoxazol-3-amine;3-AMINO-5-ETHOXYISOXAZOLE
Molecular Formula:C5H8N2O2
Molecular Weight:128.12900
HS Code:2934999090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:61.28000
Exact Mass:128.05900
LogP:1.23670
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-Amino-5-ethoxyisoxazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-AMINO-5-ETHOXYISOXAZOLE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-AMINO-5-ETHOXYISOXAZOLE Use and application,3-Amino-5-ethoxyisoxazole technical grade,usp/ep/jp grade.
Related News: If the Justice Department concludes that an internal investigation was thorough, it can result in a non-prosecution agreement with few, if any, penalties, the experts said. However, a company-led investigation that appears to have been poorly handled could lead to harsher outcomes. 3-Amino-5-ethoxyisoxazole manufacturer In addition, although the API and intermediate industries are capital-intensive and technology-intensive industries, new competitors are still joining. 3-Amino-5-ethoxyisoxazole supplier The iLet Bionic Pancreas System is a pocket-sized, wearable investigational medical device that is designed to autonomously control blood-sugar levels. 3-Amino-5-ethoxyisoxazole vendor If the Justice Department concludes that an internal investigation was thorough, it can result in a non-prosecution agreement with few, if any, penalties, the experts said. However, a company-led investigation that appears to have been poorly handled could lead to harsher outcomes. 3-Amino-5-ethoxyisoxazole factory The vaccine also proved safe during the two-year trial, in which eleven doses were administered to randomly chosen patients with mild dementia. People who received the vaccine, known as AADvac1, experienced about the same numbers of side effects and adverse events as those who were given a placebo.
